[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023GlobeNewsWire • 07/21/22
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022GlobeNewsWire • 07/21/22
Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular DiseasesBusiness Wire • 07/19/22
Roche's Elecsys Amyloid Plasma Panel granted FDA Breakthrough Device Designation to enable a timely diagnosis of Alzheimer's diseaseGlobeNewsWire • 07/19/22
Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virusGlobeNewsWire • 07/18/22
Eight-year data from APHINITY study show Roche's Perjeta-based regimen continues to reduce the risk of disease returning for people with HER2-positive early breast cancerGlobeNewsWire • 07/14/22
New two-year data confirm Roche's Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degenerationGlobeNewsWire • 07/14/22
New Two-Year Data Confirm Genentech's Vabysmo Improves Vision With Fewer Treatments for People With Wet Age-Related Macular DegenerationBusiness Wire • 07/14/22
New data from phase III HAVEN 6 study reinforce favourable safety and efficacy profile of Roche's Hemlibra in people with moderate or mild haemophilia AGlobeNewsWire • 07/11/22
New Data From Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy Profile of Genentech's Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia ABusiness Wire • 07/11/22
FDA grants Priority Review to Roche's Lunsumio for people with relapsed or refractory follicular lymphomaGlobeNewsWire • 07/06/22
FDA Grants Priority Review to Genentech's Mosunetuzumab for People With Relapsed or Refractory Follicular LymphomaBusiness Wire • 07/06/22
Roche launches new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient careGlobeNewsWire • 06/29/22
Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnosticsGlobeNewsWire • 06/28/22
The world can avoid a recession but it won't think it can until it does, says David RocheCNBC • 06/20/22